via Harvard Health
Researchers at LSU Health New Orleans Neuroscience Center of Excellence and colleagues have discovered a new class of pipeline drugs to relieve pain and reduce fever without the danger of addiction or damage to the liver or kidneys. The research is published online in the European Journal of Medicinal Chemistry.
Current drugs have unwanted side effects. Opioids can not only cause addiction; recent studies have shown they can be no more effective at relieving pain than non-narcotic drugs. Non-steroidal anti-inflammatories (NSAIDs) can cause kidney damage. Acetaminophen is an effective drug, but overuse can result in liver damage.
The research team, led by Drs. Hernan A. Bazan, a professor in the Department of Surgery and Program Director of the Vascular Surgery Fellowship at Ochsner Clinic, and Surjyadipta Bhattacharjee, a post-doctoral researcher at the LSU Health New Orleans Neuroscience Center of Excellence, set out to discover what causes the liver damage associated with acetaminophen and then create a drug structurally similar to acetaminophen — as effective, but without liver toxicity. Along with the chemistry team led by Professor Julio Alvarez-Builla, Department of Organic Chemistry at the University of Alcala in Madrid, they tested 21 different compounds as acetaminophen analogs.
Senior author Nicolas Bazan, MD, PhD, Boyd Professor and Director of LSU Health New Orleans Neuroscience Center of Excellence says, “The new chemical entities reduced pain in two in models without the liver and kidney toxicity associated with current over-the-counter analgesics that are commonly used to treat pain — acetaminophen and NSAIDs. They also reduced fever in a pyretic model. This is particularly important in the search for an antipyretic with a safer profile in the COVID-19 pandemic and its associated kidney and liver disease in critically ill SARS-CoV-2 patients.”
Acute and chronic pain management is one of the most prevalent and costly public health issues worldwide. According to the Centers for Disease Control and Prevention, an estimated 50 million — 20.4% of U.S. adults had chronic pain and 8.0% of U.S. adults had high-impact chronic pain in 2016.
“Given the widespread use of acetaminophen, the risk of hepatotoxicity with overuse, and the ongoing opioid epidemic, these new chemical entities represent novel, non-narcotic analgesics that exclude hepatotoxicity, for which development may lead to safer treatment of acute and chronic pain and fever,” adds Dr. Nicolas Bazan.
The intellectual property behind these new technologies, which are part of this discovery, have been licensed from LSU Health Sciences Center New Orleans to the life science startup South Rampart Pharma, LLC that is currently developing this new drug in late pre-clinical stages.
“Our primary goal is to develop and commercialize new alternative pain medications that lack abuse potential and have fewer associated safety concerns than current treatment options, and this peer-reviewed paper describes the discovery of the initial library of compounds as well as several proof of concept animal and molecular studies,” says Dr. Hernan Bazan.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Acute and chronic pain management
- Unlocking the mysteries of pain
If you've visited a doctor's office anytime in the past five decades, after you've had your blood pressure taken and your weight measured, you've probably been asked that seemingly innocuous question: ...
- Chronic pain 'like walking into burning hot oven', sufferer says
Persistent pain that lasts more than three months, despite medication or other forms of treatment; Secondary chronic pain is a pain which tends to be caused by another condition, ...
- Surprise findings suggest anti-inflammatories increase chronic pain risk
A new study led by researchers at McGill University challenges current notions of how acute pain is treated. The findings suggest treating some forms of acute pain with anti-inflammatory drugs may ...
- In radical claim, study suggests inflammation wards off chronic pain instead of causing it
Luda Diatchenko investigated the underlying biology of pain like a detective chasing clue after clue: What role does this gene play? How about that protein? She always wondered, though, what she would ...
- Anti-inflammatory drugs could increase chronic pain risk, study suggests
To understand the transition from acute to chronic low back pain ... “It is also important to note that anti-inflammatory drugs are effective in short-term pain management. “There is good quality ...
Go deeper with Google Headlines on:
Acute and chronic pain management
Go deeper with Bing News on:
Alternative pain medications
- CareSTL Health plans to offer alternatives to opioids, housing, in the Greater Ville
CareSTL Health is creating a new health center in the Greater Ville neighborhood of north St. Louis. When complete next year, the Ville Wellness Center will house a drive-thru pharmacy, physical, ...
- Doctors turn to opioid alternatives for pain relief
Many people first become addicted to the power of painkillers during surgery and recovery, but now, doctors are looking to alternative methods to relieve pain and help patients.
- QC Kinetix (Naples) Providing Premier Regenerative Medicine for Pain Treatment in Naples, FL
Pain caused by old age, ailments like arthritis, and injury can affect one’s way of life. While medications such as steroids can be an alternative, they are addictive and don’t guarantee healing. QC ...
- Uganda: bee venom therapy as an alternative medicine
There are claims it works as an immune booster and an anti-aging drug. Some also believe it reduces the risk of developing cancer. But despite no clear scientific evidence to fully back up any of the ...
- Antioch woman said opioid treatment for chronic pain causes stigma
An Antioch woman with health conditions that cause her pain said opioids are her only choice to manage them. However, she said with the focus on the opioid epidemic, there's now a stigma around taking ...
